health canada approval zepbound tirzepatide obesity canada 2024 2025 has approved Wegovy® (semaglutide) for the treatment of MASH (non-cirrhotic metabolic dysfunction-associated steatohepatitis) — a serious liver disease that is one of many downstream conditions related to obesity. As many FDA approval for Zepbound (tirzepatide)
Description
Hemoglobin A1c improvements of 1 to 2 percent occur in individuals with elevated baseline values
Using a structured tirzepatide diet plan and meal planning approach can also help maximize your results regardless of provider
Brand-name tirzepatide is expensive
Tirzepatide is a peptide, and peptides degrade when exposed to heat, light, or bacterial contamination
Dietary changes and timing often accompany tirzepatide treatment
Here is what to expect and how to manage common issues
